Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
PUT
Exelon
EXC
$47.2B
| $6M | ﹤0.01% |
213,384
-22,152
| -9% | -$637K |
|
2127
CALL
Golar LNG
GLNG
$5.34B
| $6M | ﹤0.01% |
201,200
+176,600
| +718% | +$4.25M |
|
2128
CALL
ProShares Ultra Bloomberg Crude Oil
UCO
$430M
| $6M | ﹤0.01% |
40,928
-11,216
| -22% | -$1.41M |
|
2129
Boston Properties
BXP
$10.9B
| $5.99M | ﹤0.01% |
46,084
-298,625
| -87% | -$37.4M |
|
2130
CALL
American Electric Power
AEP
$68.4B
| $5.99M | ﹤0.01% |
81,400
+36,000
| +79% | +$2.69M |
|
2131
PUT
Air Products & Chemicals
APD
$68.8B
| $5.99M | ﹤0.01% |
36,500
+10,400
| +40% | +$1.66M |
|
|
ATHN
2132
DELISTED
Athenahealth, Inc.
ATHN
| $5.99M | ﹤0.01% |
45,020
-165,971
| -79% | -$21.2M |
|
2133
CALL
Invesco DB US Dollar Index Bullish Fund
UUP
$413M
| $5.99M | ﹤0.01% |
249,100
-104,500
| -30% | -$2.55M |
|
2134
CALL
Howmet Aerospace
HWM
$115B
| $5.98M | ﹤0.01% |
286,358
-64,288
| -18% | -$1.25M |
|
|
MRO
2135
CALL
DELISTED
Marathon Oil Corporation
MRO
| $5.98M | ﹤0.01% |
353,200
-431,300
| -55% | -$6.4M |
|
2136
PUT
Tenet Healthcare
THC
$21.6B
| $5.98M | ﹤0.01% |
394,400
+227,100
| +136% | +$3.2M |
|
2137
PUT
AngloGold Ashanti
AU
$48.7B
| $5.98M | ﹤0.01% |
586,400
+370,000
| +171% | +$3.57M |
|
|
AMTD
2138
CALL
DELISTED
TD Ameritrade Holding Corp
AMTD
| $5.97M | ﹤0.01% |
116,800
-83,500
| -42% | -$4.17M |
|
2139
PUT
Huntington Ingalls Industries
HII
$12.9B
| $5.96M | ﹤0.01% |
25,300
+9,900
| +64% | +$2.34M |
|
|
KMG
2140
DELISTED
KMG Chemicals Inc
KMG
| $5.96M | ﹤0.01% |
+90,185
| New | +$5.1M |
|
2141
Herbalife
HLF
$1.29B
| $5.96M | ﹤0.01% |
+175,962
| New | +$6.16M |
|
|
TRVG
2142
trivago
TRVG
$360M
| $5.96M | ﹤0.01% |
174,128
+153,545
| +746% | +$6.29M |
|
2143
iShares US Pharmaceuticals ETF
IHE
$1.64B
| $5.95M | ﹤0.01% |
115,707
-14,574
| -11% | -$749K |
|
2144
PUT
Veeva Systems
VEEV
$39.6B
| $5.95M | ﹤0.01% |
107,700
+65,900
| +158% | +$3.88M |
|
|
ESIO
2145
DELISTED
Electro Scientific Industries
ESIO
| $5.94M | ﹤0.01% |
277,250
+173,065
| +166% | +$3.47M |
|
2146
CALL
Bunge Global
BG
$21.8B
| $5.93M | ﹤0.01% |
88,400
+43,800
| +98% | +$2.98M |
|
2147
CALL
Energy Transfer Partners
ET
$72.5B
| $5.92M | ﹤0.01% |
342,900
+94,200
| +38% | +$1.6M |
|
2148
CALL
IPG Photonics
IPGP
$3.65B
| $5.91M | ﹤0.01% |
27,600
+15,600
| +130% | +$3.31M |
|
2149
CALL
PACCAR
PCAR
$68.8B
| $5.91M | ﹤0.01% |
124,650
+13,800
| +12% | +$653K |
|
2150
PUT
Vipshop
VIPS
$6.81B
| $5.91M | ﹤0.01% |
503,900
+238,000
| +90% | +$2.11M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.